Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: EHAB )

9.530 +0.050 (+0.53%)
Streaming Delayed Price Updated: 11:32 AM EDT, Jul 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 353,039
Open 9.540
Bid (Size) 9.520 (7)
Ask (Size) 9.540 (8)
Prev. Close 9.480
Today's Range 9.140 - 9.680
52wk Range 7.120 - 14.59
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Enhabit Releases Certain Preliminary Second Quarter 2024 Results
From Enhabit, Inc.
Via Business Wire
ISS Recommends Stockholders Support Meaningful Change at Enhabit by Voting the WHITE Proxy Card “FOR” Three of AREX Capital’s Nominees
From AREX Capital Management, LP
Via Business Wire

Performance

YTD
-6.20%
-6.20%
1 Month
+8.30%
+8.30%
3 Month
-8.63%
-8.63%
6 Month
-7.92%
-7.92%
1 Year
-24.60%
-24.60%

More News

Read More
ISS Recommends Stockholders Vote “FOR” a Majority of Enhabit Home Health & Hospice Director Nominees
From Enhabit, Inc.
Via Business Wire
Analyst Expectations For Enhabit's Future
Via Benzinga
Breaking Down Enhabit: 3 Analysts Share Their Views
Via Benzinga
Enhabit Home Health & Hospice Announces Date of 2024 Second Quarter Earnings Call
From Enhabit, Inc.
Via Business Wire
Enhabit Reiterates That its Current Board is Best Positioned to Deliver Enhanced Value in Letter to Stockholders
From Enhabit, Inc.
Via Business Wire
AREX Capital Expresses Disappointment in Enhabit’s Continued Excuses and Empty Promises
From AREX Capital Management, LP
Via Business Wire
Enhabit Releases Investor Presentation Demonstrating Execution of Clear Growth Strategy and Path to Unlock Shareholder Value
From Enhabit, Inc.
Via Business Wire
AREX Capital Releases Presentation Detailing Its Nominees’ Comprehensive Plan to Deliver Enduring Value for Enhabit Stockholders
From AREX Capital Management, LP
Via Business Wire
Enhabit Demonstrates Progress to Stabilize Business and Position Company for Profitable Growth
From Enhabit, Inc.
Via Business Wire
AREX Capital Sets the Record Straight Regarding Enhabit’s Misleading Assertions
From AREX Capital Management, LP
Via Business Wire
Enhabit Home Health & Hospice Named in U.S. News & World Report’s 2024-2025 Best Companies to Work For
From Enhabit, Inc.
Via Business Wire
Enhabit Details Decisive Actions to Successfully Stabilize Business and Position Company for Value Creation
From Enhabit, Inc.
Via Business Wire
AREX Capital Management Issues Letter to Enhabit Stockholders Regarding the Need for Dramatic Changes to Board Composition
From AREX Capital Management, LP
Via GlobeNewswire
Enhabit Provides Additional Details on Robust Strategic Review Process
From Enhabit, Inc.
Via Business Wire
Enhabit Announces Participation in Upcoming Goldman Sachs 45th Annual Global Healthcare Conference
From Enhabit, Inc.
Via Business Wire
Enhabit Announces Participation in Upcoming Leerink Partners Healthcare Crossroads Conference 2024
From Enhabit, Inc.
Via Business Wire
AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
From AREX Capital Management, LP
Via GlobeNewswire
EHAB Stock Earnings: Enhabit Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Enhabit Concludes Review of Strategic Alternatives
From Enhabit, Inc.
Via Business Wire
Enhabit Reports First Quarter 2024 Financial Results
From Enhabit, Inc.
Via Business Wire
Enhabit Home Health & Hospice Announces Date of 2024 First Quarter Earnings Call
From Enhabit, Inc.
Via Business Wire
Enhabit Home Health & Hospice Named a Winner of the 2024 Top Workplaces USA Award
From Enhabit, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.